Speakers

Co-Founder, Candel Therapeutics

Principal Investigator, Ragon Institute, MGH Professor of Medicine, HMS

Assistant Professor of Medicine, HMS

Chairman of the Board of Directors, Berlin Institute of Health at Charité (BIH)

Principal Investigator, Department of Neurosurgery, BWH Assistant Professor of Neurosurgery, HMS

Chief Preparedness and Continuity Officer, Mass General Brigham Associate Professor of Emergency Medicine, HMS

Managing Director, Global Investment Banking, BofA Securities

Chief, Division of Renal Medicine, BWH Samuel A. Levine Distinguished Professor of Medicine and Constantine L. Hampers Distinguished Chair, HMS

Senior Writer, STAT

President, Massachusetts General Hospital Executive Vice President, Mass General Brigham

Director, Massachusetts Host-Microbiome Center, BWH Associate Professor of Pathology, HMS

Managing Director, Head of Life Sciences Investment Banking, BofA Securities

Commissioner of Food and Drugs, US Food and Drug Administration

Chairman, Department of Neurosurgery, MGH William and Elizabeth Sweet Professor of Neurosurgery, HMS

President of Massachusetts, Northeast Region Executive, Bank of America

Medical Director of Kidney and Pancreas Transplantation, BWH Associate Professor of Medicine, HMS

Associate Scientist, Eaton-Peabody Laboratories, Mass Eye and Ear Associate Professor of Otolaryngology Head and Neck Surgery, HMS

Neurosurgeon-in-Chief and Chairman, Neurosurgery, BWH Harvey W. Cushing Professor of Neurosurgery, HMS

Assistant Professor of Neurosurgery, BWH, HMS

Partner, Lightspeed

Chief Innovation Officer, Mass General Brigham

Reporter, CNBC

Bertarelli Professor of Translational Medical Science, Neurobiology, HMS

Assistant in Neuroscience, Center for Genomic Medicine, MGH Assistant Professor of Neurology, HMS

Managing Director, Global Research, BofA Securities

Eaton Peabody Professor of Otolaryngology, HMS, Mass Eye and Ear

Director, Center for Rare Neurological Diseases, MGH Associate Professor of Neurology, HMS

President & CEO, BlueRock Therapeutics

Chairman of the Board, Bank of America Europe

Chairman & CEO, Suffolk Chair, Brigham and Women’s Hospital

Partner, Mass General Brigham Ventures

President, Novartis Gene Therapies

Clinical Director, Cellular Immunotherapy Program, MGH Assistant Professor of Medicine, HMS

Global Head of Life Sciences, Blackstone

VP, Head of Patient Advocacy, Solid Biosciences

Managing Director, Global Research, BofA Securities

Chief Scientific Officer, Mass Eye and Ear Sir William Osler Professor of Ophthalmology, HMS

Chief of Pediatric Surgery, MGH Surgeon-in-Chief, MassGeneral for Children ,

Director, Genomes2People Research Program, BWH Professor of Medicine, HMS

Assistant Investigator, Center for Genomic Medicine, MGH Assistant Professor of Neurology, HMS

Director, Chemical Neurobiology Laboratory, Center for Genomic Medicine, MGH Associate Professor of Neurology, HMS

Associate, Global Research, BofA Securities

Chief Editor, Cell & Gene

Vice President, Global Research, BofA Securities

Senior Vice President, Early Clinical Development, Hematology/Oncology & Cell Therapy, Bristol Myers Squibb

Director, Deep Brain Stimulation Program, MGH Assistant Professor of Neurology, HMS

President, Brigham and Women’s Hospital Executive Vice President, Mass General Brigham

President Emerita, MIT

Principal Investigator, Center for Cancer Research, MGH Assistant Professor of Pathology, HMS

Robert B. Colvin, M.D. Endowed Chair in Pathology & Pathologist, MGH Professor of Pathology, HMS

Richard W. Vague Professor in Immunotherapy, Director, Center for Cellular Immunotherapies, Director, Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine

President, Board of Directors, National Tay Sachs and Allied Diseases Medical Geneticist, Associate Professor of Clinical Medicine, Penn Medicine

Director, Molecular Neurobiology Laboratory, McLean Professor of Neuroscience and Psychiatry, HMS

VP, Mass General Brigham Ventures

President & Managing Partner, F-Prime Capital

Managing Director, Bain Capital Life Sciences

President, The Kraft Group Chairman of the Board of Trustees, MGH

Associate Professor of Neurology, BWH, HMS

Portfolio Manager, Citadel

Chief, Division of Infectious Diseases, BWH Harriet Ryan Albee Professor of Medicine, HMS

Molecular Biologist, MGH Professor of Genetics, HMS

Executive Chairman & Founder, Alexandria Real Estate Equities, Inc.

Chief, Division of Transplant Surgery, MGH Claude E. Welch Professor of Surgery, HMS

Director, Center for Biologics Evaluation and Research, FDA

Director, Cellular Immunotherapy Program, Cancer Center, MGH Associate Professor, Medicine, HMS

Founding Partner, Polaris Partners

Managing Director, Global Research, BofA Securities

Instructor in Neurosurgery, BWH, HMS

Managing Director & Head of Healthcare in Equity Capital Markets, BofA Securities

Mallinckrodt Professor of Genetics, Emeritus, HMS Executive Vice Chairman, Sana Biotechnology, Inc

Vice President Viral Vector Services, Thermo Fisher

Director, San Raffaele Telethon Institute for Gene Therapy

Managing Partner, Polaris Ventures

Medical Director, Cell Manipulation Core Facility, Technical Director, Immune Effector Cell Therapy Program, DFCI Assistant Professor, HMS

Executive Director, Mucolipidosis Type IV (ML4) Foundation

Neurosurgeon and Principal Investigator, BWH Assistant Professor of Neurosurgery, HMS

President, R&D, Takeda

Director, Vaccine and Immunotherapy Center, MGH Professor of Medicine, HMS

Professor, Neurology, Ann Romney Center for Neurologic Diseases, BWH Kuchroo Weiner Distinguished Professor of Neuroimmunology, BWH

Co-Director of Neuroscience, Associate Geneticist in Neurology, MGH Professor of Neurology, HMS

CMO, Abata Therapeutics Venture Partner, Third Rock Ventures

Senior Vice President, Clinical Development, PACT Pharma

VP, Head of New Platforms, Ophthalmology and Hemophilia, Bayer

VP Head of Translational Medicine, Syncopation Life Sciences

Venture Partner, GV

Director, Global Research, BofA Securities

EVP, Chief of Cell & Gene Therapies and VCGT Site Head, Vertex Pharmaceuticals

Chairman of the Board, Vir Biotechnology Chairman, Denali Therapeutics

Director, Center for Regenerative Medicine, MGH Gerald and Darlene Jordan Professor of Medicine, HMS

Neurosurgeon, MGH Assistant Professor of Neurosurgery, HMS

Director, Cardiovascular Genetics Center, BWH Smith Professor of Medicine & Genetics, HMS

Chief Scientific Officer, Executive Vice President, Intellia Therapeutics

Vice Chairman of Research, Department of Neurosurgery, BWH Professor, HMS

Institute Professor and Professor of Biology, Koch Institute for Integrative Cancer Research at MIT Co-Founder, Alnylam Pharmaceuticals, Inc.

Former Director, National Cancer Institute

Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation

Associate Chief, Infection Control Unit, MGH Associate Professor of Medicine, HMS

Scientific Director and Elizabeth G. Riley and Daniel E. Smith Jr. Endowed Chair, Mass General Research Institute Professor, Neurology, HMS

HHMI Investigator, F.M. Kirby Neurobiology Research Program, Boston Children’s Hospital Associate Professor of Neurology, HMS

Vice President, Equity Research, BofA Securities

Director, Experimental Therapeutics Unit, Director, Viral Vector Core, MGH Professor of Neurology, HMS

Grousbeck Associate Professor in Gene Therapy, Mass General Brigham (on leave)

Associate Director of the Retina Service, Mass Eye and Ear Solman and Libe Friedman Professor of Ophthalmology, Co-Director Ocular Regenerative Medical Institute, HMS

Anchor/Reporter, Bloomberg

Director, Minda de Gunzburg Center for Retinal Regeneration, Associate Scientist, Schepens Eye Research Institute, Mass Eye and Ear Associate Professor of Ophthalmology, Co-Director, Ocular Regenerative Medicine Institute, HMS

Professor, Whitehead Institute, MIT

Principal Investigator, Grousbeck Gene Therapy Center, Mass Eye and Ear Instructor in Ophthalmology, HMS

Vice President, Global Research, BofA Securities